Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Clinical
Eric Feigl-Ding
DrEricDing
BREAKING—new #COVID19 vaccine efficacy study from Israel concludes that Pfizer/BioNTech's jab is up to 85% effective after the first dose after 15 days to day 28—and even 75% including asymptomatic
Read more
Andy Maciver
akmaciver
Further to my interview with @BBCGaryR on #bbcgms earlier, here’s a little thread of my thoughts on the #SirJohnMajor intervention. Firstly, the things I think Sir John is correct about.
Read more
Carrie E. Fry, PhD
cefry437
Are you a health or education policy researcher? Health economist? Clinical epidemiologist? Do you analyze two-group/two-time-period (quasi-experimental) studies? If so, then this methods thread is for you! 1/ Inspired by
Read more
MWF
medicalwomenuk
1/4 Professors Orkin and Modi recently wrote to the Vaccine Taskforce (VTF )on behalf of the MWF to draw attention to exclusion of pregnant women, young people, children and infants
Read more
Hugh Harvey
DrHughHarvey
This is fairly unprecedented - the @US_FDA is considering waiving 510(k) regulatory approval for 84 types of class II medical devices including these AI-driven ones:https://www.federalregister.gov/documents/2021/01/15/2021-00787/making-perm
Read more
The Medical M.A.B.
Oga_DoctorBlue
I wanted to say something snarky about Dr. Immanuel's little speech, but the reality of the situation is the vast majority of Americans do not understand how good research is
Read more
Vinod Scaria
vinodscaria
Our recent preprint of genetic epidemiology of #immune #escape variants from global #SARSCoV2 genomeshttps://www.biorxiv.org/content/10.1101/2020.12.24.424332v1 A number of genetic variants in #SARSCoV2 are associated with immune escape - a
Read more
Adam Weiner
Adam_Weiner535
Weiner's 10 Rules for Peer Review, a Tweetorial!#MedTwitter #AcademicTwitter #AcademicChatter #UroSoMe @JUrology @EUplatinum @urogoldjournal @EurUrolOncol @EurUrolFocus @UrolOncol #MedEd @OpenAcademics @AcademicsSay A bit of background.
Read more
The CRUK Oxford Centre
OxfordCancer
1/ It's #WorldCancerDay . A thank you to Oxford cancer research (A thread )In Oxford there are over 900 cancer researchers, across 3 out of 4 @UniofOxford divisions and @OUHospitals
Read more
Midwestern Hedgie
MidwestHedgie
Let's talk $CYDY. As an M.D. and a human, I _hope_ their imminent phase 2B/3 trial result for severe covid-19 is a success. However, as an investor, I'm short the
Read more
Pratik Patel
mscp200
@MrZackMorris @ripster47 $ITRM DD (I am infectious disease pharmacist):Sulopenem:- first oral carbapenem, all carbapenems are IV so used in hospital. - increasing resistance to current oral abx - cipro, nitrofurantoin,
Read more
Lorenzo Lorenzo-Luaces, PhD
lluaces
1/ Demystifying #AcademicTwitter faculty success: When I was a student, I thought about how much work when into my 1st pub and then saw senior faculty with X100 papers and
Read more
Ashish K. Jha, MD, MPH
ashishkjha
Heard of SARS-CoV2 variant from Japan?No?How about one from South Korea?No?Surely variants from New Zealand & Vietnam?Of course notBecause these places haven't given rise to scary variantsBut what places have.....has
Read more
Zack Chiang
z_chiang
Interesting thread on a new genomic technology getting a lot of hype. But until they release more details on how their method actually works, this is an ad, not sciencehttps://twitter.com/bionanogenomics/status/1347213793827442690
Read more
AleM 👩🏻🔬👩🏻💻 🇮🇹🇨🇦 #COVIDzero
AleM_IT_CA
1/ As a scientist and a person with moral and ethic, I am appalled about what I saw today in Québec, even if I was expecting nothing less. Because of
Read more
Paul O'154774896
antic2000
Vaccine info. A thread.https://twitter.com/mostlypeeved/status/1334087039864725506 https://www.iflscience.com/health-and-medicine/less-than-a-year-to-develop-a-covid-vaccine-heres-why-you-shouldnt-be-alarmed/amp.html?__twitter_impression=tr
Read more
‹
1
2
...
60
61
62
63
64
65
66
...
177
178
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree